IBSP and prostate carcinoma: Consistently, inhibition of AKT diminishes the expression of bone sialoprotein (BSP), OPN, pro-invasive matrix metalloproteinase-2 (MMP2), and αvβ3-integrin in prostate cancer cells, which are all proteins associated with the occurrence of bone metastases [116].